Search research articles
Contact Us
Filters
Showing results (91-100 of 106) with videos related to
Page
of 11
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
January 15, 2002
Primary thyroid lymphoma is a heterogeneous disease
C Thieblemont, A Mayer, C Dumontet, et al.
BMC Pharmacology & Toxicology
|
August 16, 2020
Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib
A Geneste, M N Duong, L Molina, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Thalidomide in patients with advanced multiple myeloma
I Yakoub-Agha, P Moreau, S Leyvraz, et al.
British Journal of Haematology
|
October 29, 1998
Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies
N Ketterer, G Salles, I Moullet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 11, 2011
The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan
O Arnaud, A Boumendjel, A Gèze, et al.
Blood
|
May 23, 1998
High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation
N Ketterer, G Salles, M Raba, et al.
Haematologica
|
May 9, 2000
Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'Adulte
R O Casasnovas, C Haioun, C Dumontet, et al.
Bone Marrow Transplantation
|
November 20, 2002
Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma
C Thieblemont, C Dumontet, H Saad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1997
Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years
Y Bastion, J Y Blay, M Divine, et al.
Bone
|
February 7, 2020
Tissue-nonspecific alkaline phosphatase is an anti-inflammatory nucleotidase
L Bessueille, A Briolay, J Como, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 106) with videos related to
Sort By:
Page
of 11
The Journal of Clinical Endocrinology and Metabolism
|
January 15, 2002
Primary thyroid lymphoma is a heterogeneous disease
C Thieblemont, A Mayer, C Dumontet, et al.
BMC Pharmacology & Toxicology
|
August 16, 2020
Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib
A Geneste, M N Duong, L Molina, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
March 29, 2002
Thalidomide in patients with advanced multiple myeloma
I Yakoub-Agha, P Moreau, S Leyvraz, et al.
British Journal of Haematology
|
October 29, 1998
Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies
N Ketterer, G Salles, I Moullet, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 11, 2011
The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan
O Arnaud, A Boumendjel, A Gèze, et al.
Blood
|
May 23, 1998
High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation
N Ketterer, G Salles, M Raba, et al.
Haematologica
|
May 9, 2000
Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'Adulte
R O Casasnovas, C Haioun, C Dumontet, et al.
Bone Marrow Transplantation
|
November 20, 2002
Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma
C Thieblemont, C Dumontet, H Saad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1997
Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years
Y Bastion, J Y Blay, M Divine, et al.
Bone
|
February 7, 2020
Tissue-nonspecific alkaline phosphatase is an anti-inflammatory nucleotidase
L Bessueille, A Briolay, J Como, et al.
Page
of 11